{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:40:50Z","timestamp":1790851250112,"version":"4.1.0"},"reference-count":378,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Conventional home blood glucose measurements require a sample of blood that is obtained by puncturing the skin at the fingertip. To avoid the pain associated with this procedure, there is high demand for medical products that allow glucose monitoring without blood sampling. In this review article, all such products are presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In order to identify such products, four different sources were used: (1) PubMed, (2) Google Patents, (3) Diabetes Technology Meeting Startup Showcase participants, and (4) experts in the field of glucose monitoring. The information obtained were filtered by using two inclusion criteria: (1) regulatory clearance, and\/or (2) significant coverage in Google News starting in the year 2016, unless the article indicated that the product had been discontinued. The identified bloodless monitoring products were classified into three categories: (1) noninvasive optical, (2) noninvasive fluid sampling, and (3) minimally invasive devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 28 noninvasive optical, 6 noninvasive fluid sampling, and 31 minimally invasive glucose monitoring products were identified. Subsequently, these products were characterized according to their regulatory, technological, and consumer features. Products with regulatory clearance are described in greater detail according to their advantages and disadvantages, and with design images.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on favorable technological features, consumer features, and other advantages, several bloodless products are commercially available and promise to enhance diabetes management. Paths for future products are discussed with an emphasis on understanding existing barriers related to both technical and non-technical issues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19322968211007212","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:38:16Z","timestamp":1623631096000},"page":"168-214","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":66,"title":["Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-9336","authenticated-orcid":false,"given":"Trisha","family":"Shang","sequence":"first","affiliation":[{"name":"Diabetes Technology Society, Burlingame, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-9777","authenticated-orcid":false,"given":"Jennifer Y.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Diabetes Technology Society, Burlingame, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-2793","authenticated-orcid":false,"given":"Andreas","family":"Thomas","sequence":"additional","affiliation":[{"name":"AGDT (Working group of Diabetes Technology), Germany, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-1863","authenticated-orcid":false,"given":"Mark A.","family":"Arnold","sequence":"additional","affiliation":[{"name":"University of Iowa, Department of Chemistry, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-472X","authenticated-orcid":false,"given":"Beatrice N.","family":"Vetter","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Science Consulting in Diabetes GmbH, Neuss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-6862","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"additional","affiliation":[{"name":"Mills-Peninsula Medical Center, San Mateo, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,6,13]]},"reference":[{"key":"bibr1-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S007"},{"key":"bibr2-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009122.pub2"},{"key":"bibr3-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5887"},{"key":"bibr4-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028576"},{"key":"bibr5-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3390\/s19040800"},{"key":"bibr6-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400501"},{"key":"bibr7-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000342"},{"key":"bibr8-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3390\/bios11030064"},{"key":"bibr9-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2014.12.001"},{"key":"bibr10-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.19.1839"},{"key":"bibr11-19322968211007212","unstructured":"Nemaura Medical. Nemaura Medical. Accessed December 14, 2020. https:\/\/nemauramedical.com\/"},{"key":"bibr12-19322968211007212","unstructured":"Cai A, Gutow H, Mahoney K, et al. CGM 4Q20 industry roundup \u2013 record CGM sales of $1.6 billion, rising 26% YOY \u2013 March 9, 2021. Close Concerns Knowledgebase. March 9, 2021. Accessed March 15, 2021. https:\/\/www.closeconcerns.com\/knowledgebase\/r\/be9b1ac7"},{"key":"bibr13-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3390\/s20051251"},{"key":"bibr14-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3390\/s20236925"},{"key":"bibr15-19322968211007212","unstructured":"Lee I, Probst D, Klonoff D, Sode K. Continuous glucose monitoring systems - current status and future perspectives of the flagship technologies in biosensor research. In press."},{"key":"bibr16-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818798347"},{"key":"bibr17-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1080\/05704928.2018.1486324"},{"key":"bibr18-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-018-1395-x"},{"key":"bibr19-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820936224"},{"key":"bibr20-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.medengphy.2007.06.003"},{"key":"bibr21-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9628281"},{"key":"bibr22-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s10396-018-0892-z"},{"key":"bibr23-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s12046-019-1118-9"},{"key":"bibr24-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1109\/ICTC49870.2020.9289629"},{"key":"bibr25-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1373\/49.6.924"},{"key":"bibr26-19322968211007212","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v11.i11.489"},{"key":"bibr27-19322968211007212","unstructured":"U.S. Food and Drug Administration. Pulse oximeter accuracy and limitations: FDA safety communication. FDA. February 19, 2021. Accessed February 26, 2021. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/pulse-oximeter-accuracy-and-limitations-fda-safety-communication"},{"key":"bibr28-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s10877-005-1655-0"},{"key":"bibr29-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17076"},{"key":"bibr30-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.18.1.017007"},{"key":"bibr31-19322968211007212","unstructured":"PubMed. PubMed \u201cNoninvasive Glucose\u201d search. Accessed February 10, 2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=noninvasive+glucose&sort=date&size=200"},{"key":"bibr32-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979846"},{"key":"bibr33-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1097\/00004669-199707000-00017"},{"key":"bibr34-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.3.433"},{"key":"bibr35-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.2.165"},{"key":"bibr36-19322968211007212","unstructured":"Hanssen JHL, Biosensor Tweehuysen R. Published online April 28, 2020. Accessed December 14, 2020. https:\/\/patents.google.com\/patent\/US10631769B2\/en?assignee=noviosense&oq=noviosense"},{"key":"bibr37-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3390\/s17081866"},{"key":"bibr38-19322968211007212","unstructured":"Adams C. FDA approves device to help diabetics measure sugar levels. Wall Street Journal. March 23, 2001. Accessed February 9, 2021. https:\/\/www.wsj.com\/articles\/SB985288166651518746"},{"key":"bibr39-19322968211007212","doi-asserted-by":"publisher","DOI":"10.3109\/07853890009002034"},{"key":"bibr40-19322968211007212","unstructured":"Statland BE. Glucowatch automatic glucose biographer approval order statement. March 22, 2001. Accessed March 1, 2021. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P990026A.pdf"},{"key":"bibr41-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.210"},{"key":"bibr42-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.8.1929"},{"key":"bibr43-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814536138"},{"key":"bibr44-19322968211007212","unstructured":"Echo Therapeutics, Inc. Echo Therapeutics Begins Testing of NextGen CGM System Components. Cision PR Newswire. June 29, 2016. Accessed December 17, 2020. https:\/\/www.prnewswire.com\/news-releases\/echo-therapeutics-begins-testing-of-nextgen-cgm-system-components-300291837.html"},{"key":"bibr45-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02894.x"},{"key":"bibr46-19322968211007212","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.14.e510"},{"key":"bibr47-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/430426"},{"key":"bibr48-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2004.6.782"},{"key":"bibr49-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2747-5"},{"key":"bibr50-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500507"},{"key":"bibr51-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1039\/d0cs00304b"},{"key":"bibr52-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400417"},{"key":"bibr53-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229681200600602"},{"key":"bibr54-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300111"},{"key":"bibr55-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1525"},{"key":"bibr56-19322968211007212","unstructured":"Eversense XL user guide: a guide for using the Eversense XL continuous glucose monitoring system. Accessed February 9, 2021. https:\/\/global.eversensediabetes.com\/sites\/default\/files\/2019-09\/LBL-1402-28-001_Rev_B_Eversense_User_Guide_mgdL_UAE_Web.pdf"},{"key":"bibr57-19322968211007212","unstructured":"Senseonics submits PMA application for 180-day Eversense system to the FDA. BioSpace. October 5, 2020. Accessed February 9, 2021. https:\/\/www.biospace.com\/article\/senseonics-submits-pma-application-for-180-day-eversense-system-to-the-fda\/"},{"key":"bibr58-19322968211007212","unstructured":"Eversense Continuous Glucose Monitoring. Long-term continuous glucose monitor. 2019. Accessed July 15, 2020. https:\/\/www.eversensediabetes.com\/"},{"key":"bibr59-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814554797"},{"key":"bibr60-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815590154"},{"key":"bibr61-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0112"},{"key":"bibr62-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2011.0262"},{"key":"bibr63-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1109\/51.677170"},{"key":"bibr64-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1039\/c6cc03609k"},{"key":"bibr65-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/152091501300209552"},{"key":"bibr66-19322968211007212","unstructured":"POCT05Ed2. Performance Metrics for Continuous Interstitial Glucose Monitoring. 2nd ed. Clinical & Laboratory Standards Institute. Accessed February 9, 2021. https:\/\/clsi.org\/standards\/products\/point-of-care-testing\/documents\/poct05\/"},{"key":"bibr67-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817704443"},{"key":"bibr68-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0364"},{"key":"bibr69-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.8.2405"},{"key":"bibr70-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200526"},{"key":"bibr71-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01446-y"},{"key":"bibr72-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0171"},{"key":"bibr73-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818762946"},{"key":"bibr74-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13781"},{"key":"bibr75-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814526191"},{"key":"bibr76-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710355105"},{"key":"bibr77-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13981"},{"key":"bibr78-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108502"},{"key":"bibr79-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814546025"},{"key":"bibr80-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817723260"},{"key":"bibr81-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz005"},{"key":"bibr82-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296821993498"},{"key":"bibr83-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820954163"},{"key":"bibr84-19322968211007212","unstructured":"510(k) Premarket Notification. Accessed March 5, 2021. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm"},{"key":"bibr85-19322968211007212","unstructured":"Welsh Company Makes Breakthrough in Diabetes Management. Business News Wales. March 8, 2020. Accessed December 14, 2020. https:\/\/businessnewswales.com\/welsh-company-makes-breakthrough-in-diabetes-management\/"},{"key":"bibr86-19322968211007212","unstructured":"Afon Technology. Glucose monitoring. Accessed December 17, 2020. https:\/\/afontechnology.com\/"},{"key":"bibr87-19322968211007212","doi-asserted-by":"publisher","DOI":"10.18481\/2077-7566-2018-14-2-12-18"},{"key":"bibr88-19322968211007212","unstructured":"Technology. Alertgy\n                      TM\n                      . Accessed December 14, 2020. https:\/\/www.alertgy.com\/technology\/"},{"key":"bibr89-19322968211007212","unstructured":"39 Potential Continuous Glucose Monitors Coming Soon. Healthline. February 20, 2020. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/39-new-cgms-for-diabetes"},{"key":"bibr90-19322968211007212","unstructured":"Apple patent hints at non-invasive glucose monitoring tech for Apple Watch. AppleInsider. Accessed December 14, 2020. https:\/\/appleinsider.com\/articles\/18\/08\/23\/apple-patent-suggests-work-on-non-invasive-glucose-monitoring-tech"},{"key":"bibr91-19322968211007212","unstructured":"Kangas MM, Arbore MA, Simon DI, Bishop MJ, Hillendahl JW, Chen R. Reference switch architectures for noncontact sensing of substances. August 23, 2018. Accessed February 5, 2021. https:\/\/patents.google.com\/patent\/US20180238794A1\/en?oq=20180238794"},{"key":"bibr92-19322968211007212","unstructured":"Non-Invasive Blood Glucose Monitoring Devices Market: New Study Offers Insights for 2017-2027. PharmiWeb.com. Accessed December 14, 2020. https:\/\/www.pharmiweb.com\/press-release\/2019-03-20\/non-invasive-blood-glucose-monitoring-devices-market-new-study-offers-insights-for-2017-2027"},{"key":"bibr93-19322968211007212","unstructured":"Karstang T, Schoenfelder S. Wearable blood glucose sensor. April 15, 2020. Accessed February 5, 2021. https:\/\/patents.google.com\/patent\/EP3636141A1\/en?q=glucose+monitor&assignee=prediktor+medical"},{"key":"bibr94-19322968211007212","unstructured":"Brolis develops laser sensor for non-invasive blood analysis - news. Compound Semiconductor. Accessed December 14, 2020. \/article\/109183\/Brolis_develops_laser_sensor_for_non-invasive_blood_analysis"},{"key":"bibr95-19322968211007212","unstructured":"Vizbaras A, Vizbaras K, Simonyte leva, Roelkens G. Tunable hybrid II-V IV laser sensor system-on-a chip for real-time monitoring of a blood constituent concentration level. March 5, 2020. Accessed February 5, 2021. https:\/\/patents.google.com\/patent\/US20200069225A1\/en?q=glucose&assignee=brolis&oq=brolis+glucose"},{"key":"bibr96-19322968211007212","unstructured":"15 Healthcare Companies in Dallas Pioneering Innovations Across the Industry. Built In. Accessed January 4, 2021. https:\/\/builtin.com\/dallas\/healthcare-companies-in-dallas"},{"key":"bibr97-19322968211007212","unstructured":"Socrates Announces Patent for New Technique for Their Noninvasive Blood Glucose Monitor \u2013 Socrates Health Solutions. Accessed February 5, 2021. https:\/\/socrateshealthsolutions.com\/socrates-announces-patent-for-new-technique-for-their-noninvasive-blood-glucose-monitor\/"},{"key":"bibr98-19322968211007212","unstructured":"Bordelon M. Methods and apparatus for optical non-invasive blood glucose change indication. July 21, 2016. Accessed January 4, 2021. https:\/\/patents.google.com\/patent\/US20160206232A1\/en?q=socrates+health+glucose+monitor&oq=socrates+health+glucose+monitor"},{"key":"bibr99-19322968211007212","unstructured":"Watch: This device uses light to help diabetics test glucose levels. BusinessInsider. Accessed December 14, 2020. https:\/\/www.businessinsider.co.za\/this-company-has-developed-a-non-invasive-glucose-monitoring-watch-2018-12"},{"key":"bibr100-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820936634"},{"key":"bibr101-19322968211007212","unstructured":"Diamontech submits to FDA pre-submission application for non-invasive blood glucose meter D-base. DiaMonTech. September 9, 2020. Accessed January 20, 2021. https:\/\/www.diamontech.de\/pressemeldungen-en\/diamontech-submits-to-fda-pre-submission-application-for-non-invasive-blood-glucose-meter-d-base"},{"key":"bibr102-19322968211007212","unstructured":"DiaMonTech: non-invasive glucose measurement. Accessed December 15, 2020. https:\/\/www.diamontech.de\/home"},{"key":"bibr103-19322968211007212","unstructured":"M\u00e4ntele W, Rafael MAP, Lieblein T, et al. Nicht-invasive stoffanalyse. October 30, 2019. Accessed February 5, 2021. https:\/\/patents.google.com\/patent\/EP3155401B1\/en?q=glucose&assignee=diamontech&oq=diamontech+glucose"},{"key":"bibr104-19322968211007212","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr105-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820947112"},{"key":"bibr106-19322968211007212","unstructured":"Patented Raman Spectroscopy. Accessed December 15, 2020. https:\/\/www.rspsystems.com\/technology\/"},{"key":"bibr107-19322968211007212","unstructured":"Ferreira R. Glucose monitoring startup GlucoActive from Poland wins pitch competition at Collision from Home. EU-Startups. June 26, 2020. Accessed December 14, 2020. https:\/\/www.eu-startups.com\/2020\/06\/glucose-monitoring-startup-glucoactive-from-poland-wins-pitch-competition-at-collision-from-home\/"},{"key":"bibr108-19322968211007212","unstructured":"Start-up Genki Vantage takes the sting out of blood glucose testing. PRUnderground. Accessed December 14, 2020. https:\/\/www.prunderground.com\/start-up-genki-vantage-takes-the-sting-out-of-blood-glucose-testing\/00182194\/"},{"key":"bibr109-19322968211007212","unstructured":"About Gluco Quantum. Accessed December 14, 2020. https:\/\/www.glucoquantum.com\/about"},{"key":"bibr110-19322968211007212","unstructured":"Quantum \u00ae G Certification. Gluco Quantum. June 13, 2020. Accessed December 14, 2020. https:\/\/www.glucoquantum.com\/post\/certification"},{"key":"bibr111-19322968211007212","unstructured":"Diabetes CRF-20\/11\/2019 5 mins-Tops. Needle-free diabetes care: 8 devices that painlessly measure blood glucose. Labiotech.eu. November 20, 2019. Accessed December 14, 2020. https:\/\/www.labiotech.eu\/diabetes\/needle-free-glucose-monitoring-for-diabetes-medtech\/"},{"key":"bibr112-19322968211007212","unstructured":"Key patent granted for Glucosense\u2019s technology. NetScientific. July 15, 2015. Accessed February 8, 2021. https:\/\/netscientific.net\/2015\/07\/15\/key-patent-granted-for-glucosenses-technology\/"},{"key":"bibr113-19322968211007212","unstructured":"Device that uses forearm to measure glucose developed. Latest news for the medical device industry. Med-Tech Innovation. December 3, 2019. Accessed December 14, 2020. https:\/\/www.med-technews.com\/api\/content\/ce20b8e6-15c5-11ea-aed5-1244d5f7c7c6\/"},{"key":"bibr114-19322968211007212","unstructured":"Inc IA. Integrity applications names Shalom Shushan as chief technology officer. GlobeNewswire News Room. November 5, 2020. Accessed December 14, 2020. http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121139\/0\/en\/Integrity-Applications-Names-Shalom-Shushan-as-Chief-Technology-Officer.html"},{"key":"bibr115-19322968211007212","unstructured":"Integrity applications receives CE mark approval for multiple improvements to GlucoTrack\u00ae model DF-F. Integrity Applications. Accessed December 14, 2020. http:\/\/www.integrity-app.com\/pressreleases\/integrity-applications-receives-ce-mark-approval-for-multiple-improvements-to-glucotrack-model-df-f\/"},{"key":"bibr116-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2018.1423987"},{"key":"bibr117-19322968211007212","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr118-19322968211007212","unstructured":"Two Innovative Wearables Took Diabetes Control to the Next Level at CES 2020. Accessed December 14, 2020. https:\/\/www.healthtechzone.com\/topics\/healthcare\/articles\/2020\/01\/24\/444307-two-innovative-wearables-took-diabetes-control-the-next.htm"},{"key":"bibr119-19322968211007212","unstructured":"Glutrac. Accessed December 15, 2020. https:\/\/add-care.net\/"},{"key":"bibr120-19322968211007212","unstructured":"Corp WM& T. Launch of world\u2019s first wearable, non-invasive, continuous, blood glucose estimation technology using WRMT\u2019s smart wristband, Helo, will generate recurring revenues for WRMT. Accessed January 25, 2021. https:\/\/www.prnewswire.com\/news-releases\/launch-of-worlds-first-wearable-non-invasive-continuous-blood-glucose-estimation-technology-using-wrmts-smart-wristband-helo-will-generate-recurring-revenues-for-wrmt-300388644.html"},{"key":"bibr121-19322968211007212","unstructured":"HELO Extense FAQ. Accessed February 8, 2021. https:\/\/website.worldgn.com\/wp-content\/uploads\/2019\/02\/Extense-FAQ-v1.1.pdf"},{"key":"bibr122-19322968211007212","unstructured":"Balajadia LF, Galdi F. Personal healthcare device. December 13, 2018. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20180353137A1\/en?assignee=helo+corp"},{"key":"bibr123-19322968211007212","unstructured":"LifePlus announces world\u2019s first non-invasive continous blood glucose monitoring wearable. May 16, 2018. Accessed December 14, 2020. https:\/\/www.businesswire.com\/news\/home\/20180516005422\/en\/LifePlus-Announces-World%E2%80%99s-First-Non-Invasive-Continous-Blood-Glucose-Monitoring-Wearable"},{"key":"bibr124-19322968211007212","unstructured":"Startup LifePlus announces noninvasive CGM wearable currently in testing. MobiHealthNews. May 17, 2018. Accessed February 8, 2021. https:\/\/www.mobihealthnews.com\/content\/startup-lifeplus-announces-noninvasive-cgm-wearable-currently-testing"},{"key":"bibr125-19322968211007212","unstructured":"Inc M. UPDATE: Movano Inc. exits stealth mode and secures $10M in additional funding to transform glucose monitoring with non-invasive technology. GlobeNewswire News Room. July 14, 2020. Accessed December 14, 2020. http:\/\/www.globenewswire.com\/news-release\/2020\/07\/14\/2062224\/0\/en\/UPDATE-Movano-Inc-Exits-Stealth-Mode-and-Secures-10M-in-Additional-Funding-to-Transform-Glucose-Monitoring-with-Non-Invasive-Technology.html"},{"key":"bibr126-19322968211007212","unstructured":"Movano Inc. Accessed December 15, 2020. https:\/\/movano.com\/solution"},{"key":"bibr127-19322968211007212","unstructured":"One of the patents that the \u201cSecret Apple Team\u201d was working on for diabetes testing for Apple Watch surfaces. Patently Apple. Accessed January 4, 2021. https:\/\/www.patentlyapple.com\/patently-apple\/2018\/08\/one-of-the-patents-that-the-secret-apple-team-was-working-on-for-diabetes-testing-for-apple-watch-surfaces.html"},{"key":"bibr128-19322968211007212","unstructured":"Islam MN. Near-infrared lasers for non-invasive monitoring of glucose, ketones, HBA1C, and other blood constituents. October 29, 2015. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20150305658A1\/en?q=glucose+monitor&assignee=omni+medsci&oq=omni+medsci+glucose+monitor"},{"key":"bibr129-19322968211007212","unstructured":"A closer look at biosensor technology at sensors USA 2019. IDTechEx. November 1, 2019. Accessed January 4, 2021. https:\/\/www.idtechex.com\/en\/research-article\/a-closer-look-at-biosensor-technology-at-sensors-usa-2019\/18604"},{"key":"bibr130-19322968211007212","unstructured":"Newberry RS. System and method for health monitoring using a non-invasive, multi-band biosensor. May 9, 2017. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US9642578B2\/en?q=glucose+monitor&assignee=sanmina&oq=sanmina+glucose+monitor"},{"key":"bibr131-19322968211007212","unstructured":"Ltd CM. CNOGA medical appointed ARTECH to distribute their non-invasive medical devices in Italy. Accessed December 14, 2020. https:\/\/www.prnewswire.com\/news-releases\/cnoga-medical-appointed-artech-to-distribute-their-non-invasive-medical-devices-in-italy-581493111.html"},{"key":"bibr132-19322968211007212","unstructured":"CNOGA medical appointed ARTECH to distribute their non-invasive medical devices in Italy - Cnoga medical. Accessed December 14, 2020. https:\/\/cnogacare.co\/artech-distribute-non-invasive-devices-italy\/"},{"key":"bibr133-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819883306"},{"key":"bibr134-19322968211007212","unstructured":"Know Labs signs research agreement with Mayo Clinic. MassDevice. July 21, 2020. Accessed December 15, 2020. https:\/\/www.massdevice.com\/know-labs-signs-research-agreement-with-mayo-clinic\/"},{"key":"bibr135-19322968211007212","unstructured":"Know Labs Granted Patent for its Bio-RFID\n                      TM\n                      Technology. April 7, 2020. Accessed December 15, 2020. https:\/\/www.businesswire.com\/news\/home\/20200407005221\/en\/Know-Labs-Granted-Patent-for-its-Bio-RFID%E2%84%A2-Technology"},{"key":"bibr136-19322968211007212","unstructured":"Gudibande RR, Radhakrishnan S. Replaceable sensor systems and methods. September 26, 2019. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/WO2019183279A1\/en?q=glucose+monitor&assignee=graphwear"},{"key":"bibr137-19322968211007212","unstructured":"Health care innovators strive to make a difference. MIT News. Massachusetts Institute of Technology. Accessed December 15, 2020. https:\/\/news.mit.edu\/2020\/health-care-innovators-strive-to-make-difference-0123"},{"key":"bibr138-19322968211007212","unstructured":"Inc ET. Echo therapeutics announces new patent for its non-invasive sensing technology. Accessed February 8, 2021. https:\/\/www.prnewswire.com\/news-releases\/echo-therapeutics-announces-new-patent-for-its-non-invasive-sensing-technology-300288439.html"},{"key":"bibr139-19322968211007212","unstructured":"Gbs looking to raise $20M in Nasdaq IPO to develop noninvasive SARS-CoV-2 diagnostic. Accessed December 15, 2020. https:\/\/www.bioworld.com\/articles\/499955-gbs-looking-to-raise-20m-in-nasdaq-ipo-to-develop-noninvasive-sars-cov-2-diagnostic"},{"key":"bibr140-19322968211007212","unstructured":"FAQs. GBS Inc. Accessed December 15, 2020. https:\/\/gbs.inc\/faqs\/"},{"key":"bibr141-19322968211007212","unstructured":"Nemaura Medical expands painless sugarBEAT glucose monitor footprint in Europe, and eyes entry into US market. Proactiveinvestors NA. August 4, 2020. Accessed December 15, 2020. https:\/\/www.proactiveinvestors.com\/companies\/news\/925727\/nemaura-medical-expands-painless-sugarbeat-glucose-monitor-footprint-in-europe-and-eyes-entry-into-us-market-925727.html"},{"key":"bibr142-19322968211007212","unstructured":"Nemaura announces CE mark approval of SugarBEAT\u00ae. Nemaura Medical. May 29, 2019. Accessed December 15, 2020. https:\/\/nemauramedical.com\/nemaura-announces-ce-mark-approval-of-sugarbeat\/"},{"key":"bibr143-19322968211007212","unstructured":"Nemaura medical submits PMA application for sugarBEAT\u00ae to U.S. FDA. BioSpace. Published July 7, 2020. Accessed January 12, 2021. https:\/\/www.biospace.com\/article\/nemaura-medical-submits-pma-application-for-sugarbeat-to-u-s-fda\/"},{"key":"bibr144-19322968211007212","unstructured":"NovioSense announces positive clinical trial results of tear glucose measurement technology. Medgadget. Accessed December 15, 2020. https:\/\/www.medgadget.com\/2018\/10\/noviosense-announces-positive-clinical-trial-results-of-tear-glucose-measurement-technology.html"},{"key":"bibr145-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964844"},{"key":"bibr146-19322968211007212","unstructured":"admin. CGM for 2020 \u2013 will new entrants reduce costs? Diabettech - Diabetes and Technology. Published December 10, 2019. Accessed December 16, 2020. https:\/\/www.diabettech.com\/cgm\/cgm-for-2020-will-new-entrants-reduce-costs\/"},{"key":"bibr147-19322968211007212","unstructured":"Continuous Glucose Monitoring System-MicroTech Medical Inc. Accessed December 16, 2020. http:\/\/www.microtechmd.com\/en\/Products\/CGMS"},{"key":"bibr148-19322968211007212","unstructured":"Inc B. Biolinq announces results from first-in-man clinical studies showing feasibility of a novel, minimally invasive approach to continuous glucose monitoring in the dermis. Accessed December 15, 2020. https:\/\/www.prnewswire.com\/news-releases\/biolinq-announces-results-from-first-in-man-clinical-studies-showing-feasibility-of-a-novel-minimally-invasive-approach-to-continuous-glucose-monitoring-in-the-dermis-301076992.html"},{"key":"bibr149-19322968211007212","unstructured":"Biolinq. Intelligent continuous glucose monitoring system. Accessed December 15, 2020. https:\/\/www.biolinq.me\/"},{"key":"bibr150-19322968211007212","unstructured":"Lee MH, Kim MH, Lee UK, et al. Electrochemical biosensor with improved accuracy. September 5, 2017. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US9753004B2\/en?q=glucose+monitor&assignee=i-sens"},{"key":"bibr151-19322968211007212","unstructured":"Inc WT. WaveForm Technologies Inc. Awarded CE mark approval for their continuous glucose monitoring system. Accessed December 15, 2020. https:\/\/www.prnewswire.com\/news-releases\/waveform-technologies-inc-awarded-ce-mark-approval-for-their-continuous-glucose-monitoring-system-300952002.html"},{"key":"bibr152-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964574"},{"key":"bibr153-19322968211007212","unstructured":"Ascensia diabetes care announces partnership; new CGM products. dLife. January 24, 2019. Accessed December 15, 2020. https:\/\/dlife.com\/ascensia-diabetes-care-announces-partnership-new-cgm-products\/"},{"key":"bibr154-19322968211007212","unstructured":"Chinese CGM maker POCTech raises $15m in Series B. MassDevice. April 17, 2017. Accessed December 15, 2020. https:\/\/www.massdevice.com\/chinese-cgm-maker-poctech-raises-15m-series-b\/"},{"key":"bibr155-19322968211007212","unstructured":"Why Dexcom diabetes CGM technology is so hot. Healthline. September 16, 2020. Accessed December 14, 2020. https:\/\/www.healthline.com\/diabetesmine\/dexcom-technology-overview"},{"key":"bibr156-19322968211007212","unstructured":"U.S. Food and Drug Administration. FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices. FDA. March 24, 2020. Accessed December 15, 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-first-fully-interoperable-continuous-glucose-monitoring-system-streamlines-review"},{"key":"bibr157-19322968211007212","unstructured":"Dexcom lands CE Mark for G6 glucose monitor. MassDevice. Published June 9, 2020. Accessed December 15, 2020. https:\/\/www.massdevice.com\/dexcom-lands-ce-mark-for-g6-glucose-monitor\/"},{"key":"bibr158-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820955228"},{"key":"bibr159-19322968211007212","unstructured":"Discover Dexcom continuous glucose monitoring (CGM) technology. Dexcom Provider. Accessed December 15, 2020. https:\/\/provider.dexcom.com\/dexcom-cgm"},{"key":"bibr160-19322968211007212","unstructured":"Crumly J. DexCom has a lot to prove in 2021. The Motley Fool. December 9, 2020. Accessed January 4, 2021. https:\/\/www.fool.com\/investing\/2020\/12\/09\/dexcom-has-a-lot-to-prove-in-2021\/"},{"key":"bibr161-19322968211007212","unstructured":"Incorporated G. GlySens incorporated closes incremental $15 million financing supporting on-going clinical evaluations and first-in-man study of the third generation Eclipse\u00ae 3 ICGM\u00ae system. Accessed January 4, 2021. https:\/\/www.prnewswire.com\/news-releases\/glysens-incorporated-closes-incremental-15-million-financing-supporting-on-going-clinical-evaluations-and-first-in-man-study-of-the-third-generation-eclipse-3-icgm-system-301074892.html"},{"key":"bibr162-19322968211007212","unstructured":"Routh T, Lucisano J, Markle W, Perkins M. Analyte sensor receiver apparatus and methods. June 7, 2018. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20180153450A1\/en?q=glucose+monitor&assignee=glysens&oq=glysens+glucose+monitor"},{"key":"bibr163-19322968211007212","unstructured":"Struggling Senseonics allies with blood glucose monitoring giant Ascensia, taps much-needed $80M. MedTech Dive. Accessed December 15, 2020. https:\/\/www.medtechdive.com\/news\/struggling-senseonics-allies-with-blood-glucose-monitoring-giant-ascensia\/583270\/"},{"key":"bibr164-19322968211007212","unstructured":"Premarket Approval (PMA). Accessed February 9, 2021. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P160048"},{"key":"bibr165-19322968211007212","unstructured":"Senseonics announces CE mark approval of the Eversense\u00ae CGM system. Accessed December 15, 2020. https:\/\/www.senseonics.com\/investor-relations\/news-releases\/2016\/05-10-2016-224122137"},{"key":"bibr166-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001193"},{"key":"bibr167-19322968211007212","unstructured":"FDA approves nonadjunctive indication for Eversense CGM. Accessed February 9, 2021. https:\/\/www.healio.com\/news\/endocrinology\/20190607\/fda-approves-nonadjunctive-indication-for-eversense-cgm"},{"key":"bibr168-19322968211007212","unstructured":"Invest in the future of blood glucose monitoring \u2022 EyeSense GmbH [EN]. EyeSense GmbH [EN]. Accessed February 8, 2021. https:\/\/en.eyesense.com\/invest-in-the-future-of-blood-glucose-monitoring\/"},{"key":"bibr169-19322968211007212","unstructured":"Abbott\u2019s FreeStyle\u00ae Libre 14 day system now available in U.S. for hospitalized patients with diabetes during COVID-19 pandemic. Accessed December 15, 2020. https:\/\/www.prnewswire.com\/news-releases\/abbotts-freestyle-libre-14-day-system-now-available-in-us-for-hospitalized-patients-with-diabetes-during-covid-19-pandemic-301037529.html"},{"key":"bibr170-19322968211007212","unstructured":"Health C for D and R. Freestyle Libre 14 day flash glucose monitoring system - P160030\/S017. FDA. March 29, 2019. Accessed December 15, 2020. https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/freestyle-libre-14-day-flash-glucose-monitoring-system-p160030s017"},{"key":"bibr171-19322968211007212","unstructured":"Abbott receives CE mark for FreeStyle\u00ae Libre, a revolutionary glucose monitoring system for people with diabetes. Abbott MediaRoom. Accessed December 15, 2020. https:\/\/abbott.mediaroom.com\/2014-09-03-Abbott-Receives-CE-Mark-for-FreeStyle-Libre-a-Revolutionary-Glucose-Monitoring-System-for-People-with-Diabetes"},{"key":"bibr172-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00294"},{"key":"bibr173-19322968211007212","unstructured":"Abbott\u2019s Freestyle Libre system becomes first CGM to be FDA cleared for use without fingersticks. MobiHealthNews. September 27, 2017. Accessed December 15, 2020. https:\/\/www.mobihealthnews.com\/content\/abbotts-freestyle-libre-system-becomes-first-cgm-be-fda-cleared-use-without-fingersticks"},{"key":"bibr174-19322968211007212","unstructured":"Writer PS. FreeStyle Libre 2 sensors added to drug tariff and DND list. Latest Pharmacy News. Business Magazine - Pharmacy Business. October 28, 2020. Accessed December 15, 2020. https:\/\/www.pharmacy.biz\/freestyle-libre-2-sensors-added-to-drug-tariff-and-dnd-list\/"},{"key":"bibr175-19322968211007212","unstructured":"510(k) Premarket notification FreeStyle Libre 2 flash glucose monitoring system. Accessed December 15, 2020. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K193371"},{"key":"bibr176-19322968211007212","unstructured":"Abbott\u2019s FreeStyle\u00ae Libre 2, with optional real-time alarms, secures CE mark for use in Europe. Abbott MediaRoom. Accessed December 15, 2020. https:\/\/abbott.mediaroom.com\/2018-10-01-Abbott-s-FreeStyle-R-Libre-2-with-Optional-Real-Time-Alarms-Secures-CE-Mark-for-Use-in-Europe"},{"key":"bibr177-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819895505"},{"key":"bibr178-19322968211007212","unstructured":"NEWS: FDA OKs FreeStyle Libre 2 with real-time glucose alerts. Healthline. June 16, 2020. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/news-freestyle-libre-2-gets-approved"},{"key":"bibr179-19322968211007212","unstructured":"Abbott scores European CE mark for its FreeStyle Libre 3. MobiHealthNews. September 28, 2020. Accessed December 15, 2020. https:\/\/www.mobihealthnews.com\/news\/abbott-scores-european-ce-mark-its-freestyle-libre-3"},{"key":"bibr180-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14451"},{"key":"bibr181-19322968211007212","unstructured":"Menarini IFR. Continuous blood glucose monitoring: the Menarini diagnostics digital \u201cpatch\u201d now available. PRNewswire. June 25, 2020. Accessed December 15, 2020. https:\/\/www.prnewswire.co.uk\/news-releases\/continuous-blood-glucose-monitoring-the-menarini-diagnostics-digital-patch-now-available-880146146.html"},{"key":"bibr182-19322968211007212","unstructured":"WaveForm Diabetes (formerly Agamatrix) and Bayer CGM. Desang Diabetes Services. June 16, 2020. Accessed December 15, 2020. https:\/\/www.desang.net\/2020\/06\/waveform-diabetes-formerly-agamatrix-and-bayer-cgm\/"},{"key":"bibr183-19322968211007212","unstructured":"China Money AI. Vertex Ventures Leads Series B Round In Chinese Glucose Monitoring Device Developer Infinovo. China Money Network. July 29, 2020. Accessed December 15, 2020. https:\/\/www.chinamoneynetwork.com\/2020\/07\/29\/vertex-ventures-leads-series-b-round-in-chinese-glucose-monitoring-device-developer-infinovo"},{"key":"bibr184-19322968211007212","unstructured":"(1)Infinovo Medical Co Limited: overview. LinkedIn. Accessed December 15, 2020. https:\/\/www.linkedin.com\/company\/infinovo-medical-co-limited\/"},{"key":"bibr185-19322968211007212","unstructured":"GluSense gets funding for implantable biosensor it says could be a year-long CGM. MobiHealthNews. February 15, 2017. Accessed December 16, 2020. https:\/\/www.mobihealthnews.com\/content\/glusense-gets-funding-implantable-biosensor-it-says-could-be-year-long-cgm"},{"key":"bibr186-19322968211007212","unstructured":"Glyde CGM. GluSense. June 8, 2020. Accessed December 16, 2020. https:\/\/glusensemedical.com\/glyde-cgm-2\/"},{"key":"bibr187-19322968211007212","unstructured":"Belgian startup Indigo Diabetes scores \u20ac38 million to develop its under the skin CGM sensor. MobiHealthNews. July 27, 2020. Accessed December 15, 2020. https:\/\/www.mobihealthnews.com\/news\/belgian-startup-indigo-diabetes-scores-38-million-develop-its-under-skin-cgm-sensor"},{"key":"bibr188-19322968211007212","unstructured":"Delbeke D, Baets R, Bogaerts W, Ryckeboer EMP. Implantable sensor. October 23, 2018. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US10105081B2\/en?q=glucose+monitor&assignee=indigo+"},{"key":"bibr189-19322968211007212","unstructured":"Seed-sized sensor could redefine glucose monitoring. Healthline. Published January 18, 2018. Accessed December 16, 2020. https:\/\/www.healthline.com\/diabetesmine\/implantable-sesame-seed-sized-cgm"},{"key":"bibr190-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53680-7"},{"key":"bibr191-19322968211007212","unstructured":"Nazari MH, Mujeeb-U-Rahman M, Sencan M. Wireless sensing platform for multi-analyte sensing. June 11, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20200178801A1\/en?q=glucose+monitor&assignee=integrated+medical+sensors"},{"key":"bibr192-19322968211007212","unstructured":"One Drop Acquires Sano. One Drop. Accessed December 16, 2020. https:\/\/onedrop.today\/blogs\/press-releases\/one-drop-acquires-sano"},{"key":"bibr193-19322968211007212","unstructured":"Drop O. One Drop Acquires Sano. Accessed December 17, 2020. https:\/\/www.prnewswire.com\/news-releases\/one-drop-acquires-sano-301038963.html"},{"key":"bibr194-19322968211007212","unstructured":"Pushpala A, Szmodis A, Chapman M, Hall W, Miller S, Hafezi H. On-body microsensor for biomonitoring. September 18, 2014. Accessed December 16, 2020. https:\/\/patents.google.com\/patent\/US20140259652A1\/en"},{"key":"bibr195-19322968211007212","unstructured":"Continuous Glucose Measuring Smartwatch, K\u2019Watch glucose, expected soon. Medgadget. Accessed December 15, 2020. https:\/\/www.medgadget.com\/2018\/11\/continuous-glucose-measuring-smartwatch-kwatch-glucose-expected-soon.html"},{"key":"bibr196-19322968211007212","unstructured":"Pierart L. Syst\u00e8me de surveillance corporelle par \u00e9lectrophor\u00e8se. November 25, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/EP3740118A1\/en?q=glucose+monitor&assignee=pkvitality&oq=pkvitality+glucose+monitor"},{"key":"bibr197-19322968211007212","unstructured":"Pierart L. Syst\u00e8me de surveillance corporelle avec adh\u00e9sif. July 25, 2019. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/WO2019141743A1\/en?q=glucose+monitor&assignee=pkvitality&oq=pkvitality+glucose+monitor"},{"key":"bibr198-19322968211007212","unstructured":"Helton K, Mcmillan WA, Wisniewski N. Tissue-integrating sensors. January 23, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/AU2017264987B2\/en?q=glucose+monitor&assignee=profusa&oq=profusa+glucose+monitor"},{"key":"bibr199-19322968211007212","unstructured":"McMillan WA, Wisniewski N. Method and system for directing a localized biological response to an implant. March 10, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US10583308B2\/en?q=glucose+monitor&assignee=profusa&oq=profusa+glucose+monitor"},{"key":"bibr200-19322968211007212","unstructured":"plc M. Medtronic Guardian\n                      TM\n                      connect continuous glucose monitoring (CGM) system for diabetes now compatible with android devices. GlobeNewswire News Room. Published May 22, 2020. Accessed December 15, 2020. http:\/\/www.globenewswire.com\/news-release\/2020\/05\/22\/2037605\/0\/en\/Medtronic-Guardian-Connect-Continuous-Glucose-Monitoring-CGM-System-for-Diabetes-Now-Compatible-with-Android-Devices.html"},{"key":"bibr201-19322968211007212","unstructured":"Health C for D and R. Guardian connect system \u2013 P160007. FDA. February 9, 2019. Accessed December 15, 2020. https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/guardian-connect-system-p160007"},{"key":"bibr202-19322968211007212","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr203-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964264"},{"key":"bibr204-19322968211007212","unstructured":"Important Safety Information. Medtronic Diabetes. December 14, 2012. Accessed February 9, 2021. https:\/\/www.medtronicdiabetes.com\/important-safety-information"},{"key":"bibr205-19322968211007212","unstructured":"Hot New Technology from Medtronic Diabetes. Healthline. July 1, 2020. Accessed January 4, 2021. https:\/\/www.healthline.com\/diabetesmine\/medtronic-diabetes-technology"},{"key":"bibr206-19322968211007212","unstructured":"Botvinick E, Bremer TM. Implantable biosensor and methods of use thereof. June 7, 2016. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US9357952B2\/en?q=glucose+monitor&assignee=Metronom+Health+Inc"},{"key":"bibr207-19322968211007212","unstructured":"Bremer TM, Bartholomeusz DA. Analyte sensors and methods of manufacturing analyte sensors. January 9, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20200008719A1\/en?q=glucose+monitor&assignee=Metronom+Health+Inc"},{"key":"bibr208-19322968211007212","unstructured":"New diabetes tech will monitor both glucose and ketones. Healthline. November 23, 2020. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/new-diabetes-sensor-glucose-ketones"},{"key":"bibr209-19322968211007212","unstructured":"Shah R, Liang BC, Bowman E, Wolfe K. Multi-analyte continuous glucose monitoring. August 15, 2019. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20190246962A1\/en?q=glucose+monitor&assignee=percusense&oq=percusense+glucose+monitor"},{"key":"bibr210-19322968211007212","unstructured":"Inc L. LifeScan enters into agreement with Sanvita medical to market and distribute continuous glucose monitoring (CGM) devices. Accessed December 15, 2020. https:\/\/www.prnewswire.com\/news-releases\/lifescan-enters-into-agreement-with-sanvita-medical-to-market-and-distribute-continuous-glucose-monitoring-cgm-devices-300853566.html"},{"key":"bibr211-19322968211007212","unstructured":"Peterson TH, Winarta H, Florindi A. Continuous glucose monitoring system and method. January 16, 2020. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US20200015720A1\/en?q=glucose+monitor&assignee=sanvita&oq=sanvita+glucose+monitor"},{"key":"bibr212-19322968211007212","unstructured":"AG B. Lifecare floats on Oslo stock exchange. Accessed December 15, 2020. https:\/\/european-biotechnology.com\/up-to-date\/latest-news\/news\/lifecare-floats-on-oslo-stock-exchange.html"},{"key":"bibr213-19322968211007212","unstructured":"Lifecare - about. Accessed February 8, 2021. https:\/\/www.lifecare.no\/about-lifecare"},{"key":"bibr214-19322968211007212","unstructured":"Glucovation: A CGM sensor for the non-diabetes mainstream? Healthline. May 21, 2014. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/glucovation-cgm"},{"key":"bibr215-19322968211007212","unstructured":"Our Technology. Glucovation. Accessed February 8, 2021. http:\/\/glucovation.com\/index.php\/our-technology\/"},{"key":"bibr216-19322968211007212","unstructured":"New for diabetes: combined insulin infusion & CGM sensor! Healthline. December 12, 2019. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/combined-infusion-set-and-cgm-sensor"},{"key":"bibr217-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112221"},{"key":"bibr218-19322968211007212","unstructured":"Patents. Pacific diabetes technologies. Accessed February 8, 2021. https:\/\/www.pacificdt.com\/patents"},{"key":"bibr219-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12699"},{"key":"bibr220-19322968211007212","unstructured":"Yang C. Analyte sensing system. September 17, 2019. Accessed February 8, 2021. https:\/\/patents.google.com\/patent\/US10413224B2\/en?q=glucose+monitor&assignee=medtrum"},{"key":"bibr221-19322968211007212","unstructured":"Apple is testing a noninvasive blood glucose monitor: CNBC. FierceBiotech. Accessed December 15, 2020. https:\/\/www.fiercebiotech.com\/medical-devices\/apple-testing-a-noninvasive-blood-glucose-monitor-cnbc"},{"key":"bibr222-19322968211007212","unstructured":"Quereshi MRA, Shillingford J, Handy CM, Chaudhry MS. Novel microwave based non-invasive glucose device. Unified Citation Journals. April 12, 2020. Accessed December 15, 2020. https:\/\/www.ucjournals.com\/diabetes\/novel-microwave-based-non-invasive-glucose-device\/"},{"key":"bibr223-19322968211007212","unstructured":"AnnNIGM en. Accessed December 16, 2020. https:\/\/annnigm.com\/en"},{"key":"bibr224-19322968211007212","unstructured":"United States Patent Application: 0180238794. Accessed December 15, 2020. http:\/\/appft.uspto.gov\/netacgi\/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=16&p=1&f=G&l=50&d=PG01&S1=(apple.AANM.+AND+20180823.PD.)&OS=aanm\/apple+and+pd\/8\/23\/2018&RS=(AANM\/apple+AND+PD\/20180823)"},{"key":"bibr225-19322968211007212","unstructured":"Prediktor Medical. BioMKR: Non Invasive CGM, a glucose smartwatch. prediktormedical. Accessed December 15, 2020. https:\/\/www.prediktormedical.com"},{"key":"bibr226-19322968211007212","unstructured":"FAQ. prediktormedical. Accessed December 15, 2020. https:\/\/www.prediktormedical.com\/faq"},{"key":"bibr227-19322968211007212","unstructured":"BROLIS. Blood analysis sensor. Accessed December 15, 2020. https:\/\/brolis-sensor.com\/"},{"key":"bibr228-19322968211007212","unstructured":"Science & Tech \u2013 Socrates Health Solutions. Accessed January 4, 2021. https:\/\/socrateshealthsolutions.com\/science-and-tech\/"},{"issue":"2","key":"bibr229-19322968211007212","doi-asserted-by":"crossref","DOI":"10.1177\/1932296817733095","volume":"14","author":"Pleus S","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"bibr230-19322968211007212","unstructured":"GlucoFit. GlucoActive. Accessed December 15, 2020. https:\/\/gluco-active.com\/glucofit\/"},{"key":"bibr231-19322968211007212","unstructured":"Shenzhen Carelife Health Technology Co., Ltd. Clinical data study report of a non-invasive glucose monitor. March 10, 2020. Accessed December 15, 2020. https:\/\/cc65bd7d-0a22-48ec-98d6-1ba1faa1dead.filesusr.com\/ugd\/5f45ff_2dd728ae6a3f4399aaf8ced2089f4a51.pdf?fbclid=IwAR1Zat_kgNFPew8waQqaniCGBsWtkzpMZuh9ovM4w_Npe1EsPCud-CI5wUI"},{"key":"bibr232-19322968211007212","unstructured":"University of Leeds. Glucosense. Accessed December 15, 2020. https:\/\/www.leeds.ac.uk\/site\/custom_scripts\/profile-single.php?profileTypeID=&categoryID=2000&profileID=116"},{"key":"bibr233-19322968211007212","unstructured":"GlucoStation. GlucoActive. Accessed December 15, 2020. https:\/\/gluco-active.com\/glucostation\/"},{"key":"bibr234-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4393497"},{"key":"bibr235-19322968211007212","unstructured":"Pf\u00fctzner A, Strobl S, Sachsenheimer D, Lier A, Ramljak S, Demircik F. Evaluation of the non invasive glucose monitoring device Glucotrack in patients with type 2 diabetes and subjects with prediabetes. J Diabetes Treat. December 8, 2019. Accessed January 27, 2021. https:\/\/www.gavinpublishers.com\/articles\/research-article\/Journal-of-Diabetes-and-Treatment\/evaluation-of-the-non-invasive-glucose-monitoring-device-glucotrack-in-patients-with-type-2-diabetes-and-subjects-with-prediabetes"},{"key":"bibr236-19322968211007212","unstructured":"GlucoTrack product benefits leaflet. Accessed January 27, 2021. http:\/\/glucotrack.com.au\/development\/images\/content\/GlucoTrackApp-Leaflet.pdf"},{"key":"bibr237-19322968211007212","unstructured":"GlucoWear. GlucoActive. Accessed December 15, 2020. https:\/\/gluco-active.com\/glucowear\/"},{"key":"bibr238-19322968211007212","unstructured":"Get involved. Accessed December 15, 2020. https:\/\/gluco-wise.com\/"},{"key":"bibr239-19322968211007212","unstructured":"HELO Extense Brochure. Accessed February 9, 2021. https:\/\/website.worldgn.com\/wp-content\/uploads\/2018\/10\/HELO-EXTENSE-BROCHURE-EN-web.pdf"},{"key":"bibr240-19322968211007212","unstructured":"How LifeLeaf works. LifePlus. Accessed December 15, 2020. https:\/\/www.lifeplus.ai\/how-lifeleaf-works\/"},{"key":"bibr241-19322968211007212","unstructured":"Leabman MA. Systems for radio wave based health monitoring that utilize data derived from amplitude and\/or phase data. June 18, 2020. Accessed December 15, 2020. https:\/\/patents.google.com\/patent\/US20200187793A1\/en?assignee=movano&oq=movano"},{"key":"bibr242-19322968211007212","unstructured":"Omni MedSci Inc.: Tech innovator likes to \u201cplay where the puck is going to be.\u201d Crain\u2019s Detroit Business. July 11, 2015. Accessed January 4, 2021. https:\/\/www.crainsdetroit.com\/article\/20150711\/AWARDS1315\/150719987\/omni-medsci-inc-tech-innovator-likes-to-play-where-the-puck-is"},{"key":"bibr243-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.2525.abstracts"},{"key":"bibr244-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818758769"},{"key":"bibr245-19322968211007212","unstructured":"CoG - Hybrid Glucometer. Cnoga Medical. Accessed December 15, 2020. https:\/\/cnogacare.co\/hybridglucometer\/"},{"key":"bibr246-19322968211007212","unstructured":"FAQ \u2014 Know Labs. Accessed December 15, 2020. https:\/\/www.knowlabs.co\/faq"},{"key":"bibr247-19322968211007212","unstructured":"Inc GT. GraphWear. Accessed December 17, 2020. https:\/\/www.graphwear.co"},{"key":"bibr248-19322968211007212","unstructured":"GraphWear Technologies Inc. A clinical feasibility study of the bios device for continuous glucose monitoring in subjects with type 1 or type 2 diabetes mellitus. clinicaltrials.gov. 2020. Accessed December 30, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04226846"},{"key":"bibr249-19322968211007212","unstructured":"gSense. Nutrix. Accessed December 15, 2020. https:\/\/nutrix.tech\/gsense\/"},{"key":"bibr250-19322968211007212","unstructured":"Chuang H, Hurley JP, Kost J. Transdermal analyte monitoring systems and methods for analyte detection. September 12, 2008. Accessed December 17, 2020. https:\/\/patents.google.com\/patent\/CA2680213A1\/zh"},{"key":"bibr251-19322968211007212","unstructured":"The biosensor platform. GBS Inc. Accessed December 15, 2020. https:\/\/gbs.inc\/the-biosensor-platform\/"},{"key":"bibr252-19322968211007212","unstructured":"SugarBEAT: first no-needles glucose monitor. Healthline. October 25, 2019. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/non-invasive-sugarbeat-cgm-diabetes"},{"key":"bibr253-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.8b01429"},{"key":"bibr254-19322968211007212","unstructured":"ID F. 005 Transmitter User Manual Microtech Medical (Hangzhou). FCC ID. Accessed December 16, 2020. https:\/\/fccid.io\/2ATOV-005\/User-Manual\/UM-4349146"},{"key":"bibr255-19322968211007212","unstructured":"CGM. GlucoRx. Accessed December 16, 2020. https:\/\/www.glucorx.co.uk\/cgm\/"},{"key":"bibr256-19322968211007212","unstructured":"i-sens. i-SENS Company Presentation_Q3 2019. November 6, 2019. Accessed January 4, 2021. https:\/\/i-sens.com\/?kboard_content_redirect=60"},{"key":"bibr257-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/db18-81-LB"},{"key":"bibr258-19322968211007212","unstructured":"User manual- POC Tech. Accessed December 15, 2020. http:\/\/www.poctechcorp.com\/upload\/files\/CT100B%20System%20User%20Manual.pdf"},{"key":"bibr259-19322968211007212","unstructured":"About Us, Zhejiang POCTech Co., Ltd. Accessed December 15, 2020. http:\/\/www.poctechcorp.com\/en\/channels\/273.html"},{"key":"bibr260-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4896862"},{"key":"bibr261-19322968211007212","unstructured":"U.S. Food and Drug Administration. Evaluation of automatic class III designation for Dexcom G6 continuous glucose monitoring system: Decision Summary DEN170088. Accessed December 15, 2020. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN170088.pdf"},{"key":"bibr262-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2016.2619333"},{"key":"bibr263-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0020"},{"key":"bibr264-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0028"},{"key":"bibr265-19322968211007212","unstructured":"FiberSense technology: continuous glucose monitoring \u2022 EyeSense GmbH [EN]. EyeSense GmbH [EN]. Accessed December 15, 2020. https:\/\/en.eyesense.com\/fibersense-technology-continuous-glucose-monitoring\/"},{"key":"bibr266-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0025"},{"key":"bibr267-19322968211007212","unstructured":"Abbott Diabetes Care. Freestyle Libre 14 Day user manual. 2018. Accessed January 28, 2021. https:\/\/freestyleserver.com\/Payloads\/IFU\/2018\/ART39764-001_rev-A-Web.pdf"},{"key":"bibr268-19322968211007212","unstructured":"Abbott Laboratories. FreeStyle Libre Safety Information. FreeStyle. Accessed April 12, 2021. https:\/\/provider.myfreestyle.com\/safety-information.html"},{"key":"bibr269-19322968211007212","unstructured":"FreeStyle Libre 2 user manual. Accessed January 4, 2021. https:\/\/www.manualslib.com\/manual\/1976109\/Abbott-Freestyle-Libre-2.html"},{"key":"bibr270-19322968211007212","unstructured":"FreeStyle Libre 3: world\u2019s smallest sensor is here. Abbott Newsroom. Accessed January 4, 2021. https:\/\/www.abbott.com\/corpnewsroom\/strategy-and-strength\/freeStyle-libre-3-worlds-smallest-sensor-is-here.html"},{"key":"bibr271-19322968211007212","unstructured":"Continuous Glucose Monitoring system. GlucoMen Day. Menarini Diagnostics. Accessed December 15, 2020. https:\/\/glucomenday.com\/continuous-glucose-monitoring-system\/"},{"issue":"2","key":"bibr272-19322968211007212","first-page":"A67","volume":"15","author":"Simic A","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"bibr273-19322968211007212","unstructured":"Glunovo i3. Infinovo CGM. Accessed December 17, 2020. https:\/\/en.infinovo.com\/glunovo-i3\/"},{"key":"bibr274-19322968211007212","unstructured":"Indigo. ATTD 2020 - Video. Indigo. March 10, 2020. Accessed December 15, 2020. https:\/\/indigomed.com\/attd-2020-video\/"},{"key":"bibr275-19322968211007212","unstructured":"Accuracy of a subcutaneously inserted NIR spectrometer sensor for continuous glucose, ketone and lactate measurement in interstitial fluid: proof-of-concept in pig model - Virtual Meeting. EASD. Accessed December 15, 2020. https:\/\/www.easd.org\/virtualmeeting\/home.html#!resources\/accuracy-of-a-subcutaneously-inserted-nir-spectrometer-sensor-for-continuous-glucose-ketone-and-lactate-measurement-in-interstitial-fluid-proof-of-concept-in-pig-model"},{"key":"bibr276-19322968211007212","unstructured":"Best J. Blood, sweat, tears and big data: The new wave of innovation in managing diabetes. ZDNet. Accessed December 16, 2020. https:\/\/www.zdnet.com\/article\/blood-sweat-tears-and-big-data-the-new-wave-of-innovation-in-managing-diabetes\/"},{"key":"bibr277-19322968211007212","unstructured":"K\u2019Watch Glucose. PKvitality. Accessed December 15, 2020. https:\/\/www.pkvitality.com\/ktrack-glucose\/"},{"key":"bibr278-19322968211007212","unstructured":"PKvitality. Press Release PKvitality, November 28, 2018. Accessed December 15, 2020. https:\/\/www.pkvitality.com\/wp-content\/uploads\/2018\/11\/PKVITALITY-KWatch-CGM-21112018-EN.pdf"},{"key":"bibr279-19322968211007212","unstructured":"Our Vision. Profusa, Inc. Accessed December 17, 2020. https:\/\/profusa.com\/our-vision\/"},{"key":"bibr280-19322968211007212","unstructured":"Guardian Sensor 3 user guide. 2018. Accessed July 16, 2020. https:\/\/www.medtronicdiabetes.com\/sites\/default\/files\/library\/download-library\/user-guides\/Guardian-Sensor-3-user-guide.pdf"},{"key":"bibr281-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0087"},{"key":"bibr282-19322968211007212","unstructured":"Medtronic Synergy and Zeus. Accessed January 4, 2021. https:\/\/investorrelations.medtronic.com\/static-files\/f579d35c-220f-40e1-bf5d-49a268c091bb"},{"key":"bibr283-19322968211007212","unstructured":"Health M. Cutting edge CGM. Our technology. Metronom Health. December 16, 2020. Accessed December 16, 2020. http:\/\/metronomhealth.com\/our-technology"},{"key":"bibr284-19322968211007212","unstructured":"Continuous Monitoring. PercuSense, United States. PercuSense. Accessed December 15, 2020. https:\/\/www.percusense.com"},{"key":"bibr285-19322968211007212","unstructured":"Sanvita Medical, LLC. Pilot Clinical Evaluation: Accuracy and Precision of the Sanvita OneTouch Real Time Continuous Glucose Monitoring System. clinicaltrials.gov; 2021. Accessed January 11, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04205084"},{"key":"bibr286-19322968211007212","unstructured":"Pf\u00fctzner A, Ramljak S, Kloppstech K, et al. Miniaturization of an osmotic pressure-based glucose sensor by means of nanosensing technology. 1."},{"key":"bibr287-19322968211007212","unstructured":"Suri JT. Non-enzymatic electrochemical sensor for measuring analytes. August 3, 2017. Accessed December 15, 2020. https:\/\/patents.google.com\/patent\/US20170219521A1\/en?assignee=glucovation&oq=glucovation"},{"key":"bibr288-19322968211007212","unstructured":"Medtrum. Accessed December 15, 2020. https:\/\/www.medtrum.com\/A6.html"},{"key":"bibr289-19322968211007212","unstructured":"For diabetics. Alertgy\n                      TM\n                      . Accessed December 17, 2020. https:\/\/www.alertgy.com\/for-diabetics\/"},{"key":"bibr290-19322968211007212","unstructured":"Meet companion \u2013 Socrates health solutions. Accessed January 4, 2021. https:\/\/socrateshealthsolutions.com\/meet-companion\/"},{"key":"bibr291-19322968211007212","unstructured":"Home. GlucoActive. Accessed December 17, 2020. https:\/\/gluco-active.com\/"},{"key":"bibr292-19322968211007212","unstructured":"GlucoSense Team. GlucoSense Presentation. Accessed December 17, 2020. https:\/\/netscientific.net\/wp-content\/uploads\/2017\/03\/NetScientific-CMD-Glucosense-May2015.pdf"},{"key":"bibr293-19322968211007212","unstructured":"GlucoTrack. GlucoTrack. Accessed December 17, 2020. http:\/\/www.glucotrack.com\/about-glucotrack\/"},{"key":"bibr294-19322968211007212","unstructured":"Glucose testing via earlobe, not stressful fingersticks. Healthline. April 15, 2014. Accessed December 17, 2020. https:\/\/www.healthline.com\/diabetesmine\/glucose-testing-via-earlobe"},{"key":"bibr295-19322968211007212","unstructured":"HELO LX: most advanced health tracking wearable by wor(l)d. Accessed February 9, 2021. https:\/\/marketbolt.com\/worldglobalnetwork\/helo\/"},{"key":"bibr296-19322968211007212","unstructured":"Helo LX: the story of multi-level marketing and one overpriced health band. Wareable. July 27, 2017. Accessed January 5, 2021. https:\/\/www.wareable.com\/fitness-trackers\/helo-lx-band-multi-level-marketing-9876"},{"key":"bibr297-19322968211007212","unstructured":"Home. LifePlus. Accessed December 17, 2020. https:\/\/www.lifeplus.ai\/"},{"key":"bibr298-19322968211007212","unstructured":"Sanmina Image. Provided by Robert Newberry of Sanmina Corporation. Accessed January 15, 2021."},{"key":"bibr299-19322968211007212","unstructured":"GBS Inc. Replacing Finger-Pricks. GBS Inc. Accessed December 17, 2020. https:\/\/gbs.inc\/"},{"key":"bibr300-19322968211007212","unstructured":"Waveform Technologies. Continuous glucose monitoring solutions. Accessed December 17, 2020. https:\/\/waveformdiabetes.com\/"},{"key":"bibr301-19322968211007212","unstructured":"How It Works. Waveform. Accessed December 17, 2020. https:\/\/waveformdiabetes.com\/how-it-works\/"},{"key":"bibr302-19322968211007212","unstructured":"New Continuous Glucose Monitors in the Works: Ascensia and AgaMatrix. Healthline. January 16, 2019. Accessed December 17, 2020. https:\/\/www.healthline.com\/diabetesmine\/new-cgms-ascensia-agamatrix"},{"key":"bibr303-19322968211007212","unstructured":"Coin Specifications. U.S. Mint. Accessed December 17, 2020. https:\/\/www.usmint.gov\/learn\/coin-and-medal-programs\/coin-specifications"},{"key":"bibr304-19322968211007212","unstructured":"Can You Buy CGM Supplies at the Pharmacy? Healthline. February 19, 2020. Accessed December 17, 2020. https:\/\/www.healthline.com\/diabetesmine\/cgm-access-pharmacies"},{"key":"bibr305-19322968211007212","unstructured":"Diabetes forecast consumer guide continuous glucose monitors. Accessed December 17, 2020. http:\/\/main.diabetes.org\/dforg\/pdfs\/2020\/2020-cg-continuous-glucose-monitors.pdf?utm_source=Offline&utm_medium=Print&utm_content=cgms&utm_campaign=DF&s_src=vanity&s_subsrc=cgms"},{"key":"bibr306-19322968211007212","unstructured":"The Dex Factor \u2013 coming in 2021, Dexcom\u2019s G7 CGM sensor. Desang Diabetes Services. July 8, 2020. Accessed January 4, 2021. https:\/\/www.desang.net\/2020\/07\/the-dex-factor-coming-in-2021-dexcoms-g7-cgm-sensor\/"},{"key":"bibr307-19322968211007212","unstructured":"Technology - GlySens Incorporated. Accessed December 17, 2020. http:\/\/glysens.com\/?page_id=40"},{"key":"bibr308-19322968211007212","unstructured":"Senseonics launches program for low-cost Eversense CGM systems. MobiHealthNews. March 25, 2019. Accessed December 17, 2020. https:\/\/www.mobihealthnews.com\/content\/senseonics-launches-program-low-cost-eversense-cgm-systems"},{"key":"bibr309-19322968211007212","unstructured":"Continuous Glucose Monitoring System- Freestyle Libre 14 Day. Accessed December 17, 2020. https:\/\/www.freestyle.abbott\/us-en\/"},{"key":"bibr310-19322968211007212","unstructured":"Freestyle Libre 2: now available in U.S. Abbott Newsroom. Accessed December 17, 2020. https:\/\/www.abbott.com\/corpnewsroom\/diabetes-care\/freestyle-libre-2-now-available-in-us.html"},{"key":"bibr311-19322968211007212","unstructured":"FreeStyle Libre 3 sets new peak in diabetes care. https:\/\/www.abbott.com\/corpnewsroom\/diabetes-care\/freeStyle-libre-3-sets-new-peak-in-diabetes-care.html"},{"key":"bibr312-19322968211007212","unstructured":"FreeStyle Libre 3 cleared in Europe \u2013 smaller, thinner, and no more scanning! diaTribe. September 29, 2020. Accessed December 17, 2020. https:\/\/diatribe.org\/freestyle-libre-3-cleared-europe-smaller-thinner-and-no-more-scanning"},{"key":"bibr313-19322968211007212","unstructured":"Abbott\u2019s FreeStyle\u00ae Libre 3 system receives CE mark - features world\u2019s smallest, thinnest sensor with best-in-class performance at the same low cost for people with diabetes. Abbott MediaRoom. Accessed January 28, 2021. https:\/\/abbott.mediaroom.com\/2020-09-28-Abbotts-FreeStyle-R-Libre-3-System-Receives-CE-Mark-Features-Worlds-Smallest-Thinnest-Sensor-with-Best-in-Class-Performance-at-the-Same-Low-Cost-for-People-with-Diabetes"},{"key":"bibr314-19322968211007212","unstructured":"Pricing. Infinovo CGM. Accessed January 5, 2021. https:\/\/en.infinovo.com\/pricing\/"},{"key":"bibr315-19322968211007212","unstructured":"Hassle-free glucose monitoring with our next-gen sensor - Indigo. Accessed December 17, 2020. https:\/\/indigomed.com\/"},{"key":"bibr316-19322968211007212","unstructured":"K\u2019Watch Glucose Review smart health review. AB Smart Health Promo. April 8, 2020. Accessed December 17, 2020. https:\/\/www.absmarthealth.com\/kwatch-glucose\/"},{"key":"bibr317-19322968211007212","unstructured":"Guardian Connect CGM System. World\u2019s First Smart CGM - Medtronic. Accessed December 17, 2020. https:\/\/www.medtronicdiabetes.com\/products\/guardian-connect-continuous-glucose-monitoring-system"},{"key":"bibr318-19322968211007212","unstructured":"Medtronic Launches Stand-Alone CGM: Guardian Connect. Healthline. March 13, 2018. Accessed December 17, 2020. https:\/\/www.healthline.com\/diabetesmine\/new-medtronic-stand-alone-cgm-guardian-connect"},{"key":"bibr319-19322968211007212","unstructured":"NEWS: medtronic embraces interoperable diabetes devices. Healthline. June 10, 2019. Accessed January 4, 2021. https:\/\/www.healthline.com\/diabetesmine\/news-tidepool-loop-medtronic-and-dexcom"},{"key":"bibr320-19322968211007212","unstructured":"What\u2019s coming and what\u2019s delayed in continuous glucose monitoring? diaTribe. May 20, 2020. Accessed February 10, 2021. https:\/\/diatribe.org\/whats-coming-and-whats-delayed-continuous-glucose-monitoring"},{"key":"bibr321-19322968211007212","unstructured":"Metronom: building a better continuous glucose monitor. Healthline. March 27, 2018. Accessed December 17, 2020. https:\/\/www.healthline.com\/diabetesmine\/metronom-health-cgm"},{"key":"bibr322-19322968211007212","unstructured":"Lifecare. Sencell - continous glucose monitoring. Accessed December 17, 2020. https:\/\/www.lifecare.no\/"},{"key":"bibr323-19322968211007212","unstructured":"Sencell - driven by nature. Accessed December 17, 2020. https:\/\/www.lifecare.no\/about-sencell"},{"key":"bibr324-19322968211007212","unstructured":"Learn more. 19OCT2020. Accessed December 17, 2020. https:\/\/www.pacificdt.com\/learn-more"},{"key":"bibr325-19322968211007212","unstructured":"A6 Touchcare user manual. Accessed December 15, 2020. https:\/\/www.medtrum.com\/pdf\/0911\/UG882111GB%C2%A0A6%C2%A0TouchCare%C2%AE%C2%A0System%C2%A0Touchscreen%C2%A0User%C2%A0Guide%C2%A0V2.23-20190513.pdf"},{"key":"bibr326-19322968211007212","unstructured":"Meet sugarBEAT - sugarBEAT. Accessed January 4, 2021. https:\/\/sugarbeat.com\/"},{"key":"bibr327-19322968211007212","unstructured":"Continuous Glucose Monitoring System - Waveform Technologies. Waveform. Accessed January 4, 2021. https:\/\/waveformdiabetes.com\/continuous-glucose-monitoring\/"},{"key":"bibr328-19322968211007212","unstructured":"Dexcom G6 Set Image. Provided by David Price of Dexcom. Accessed January 5, 2021."},{"key":"bibr329-19322968211007212","unstructured":"Eversense Products - Senseonics. Accessed January 4, 2021. https:\/\/global.eversensediabetes.com\/eversense-products"},{"key":"bibr330-19322968211007212","unstructured":"FreeStyle Libre 14-Day Image. Provided by Naunihal Virdi of Abbott Diabetes Care. Accessed January 5, 2021."},{"key":"bibr331-19322968211007212","unstructured":"FreeStyle Libre 2 Image. Provided by Naunihal Virdi of Abbott Diabetes Care. Accessed January 5, 2021."},{"key":"bibr332-19322968211007212","unstructured":"FreeStyle Libre 3 Image. Provided by Naunihal Virdi of Abbott Diabetes Care. Accessed January 5, 2021."},{"key":"bibr333-19322968211007212","unstructured":"Guardian Connect System Support. Medtronic Diabetes. September 4, 2018. Accessed January 4, 2021. https:\/\/www.medtronicdiabetes.com\/customer-support\/guardian-connect-system-support"},{"key":"bibr334-19322968211007212","unstructured":"D-Band Image. Provided by DiaMonTech AG. Accessed January 5, 2021."},{"key":"bibr335-19322968211007212","unstructured":"D-Base Image. Provided by DiaMonTech AG. Accessed January 5, 2021."},{"key":"bibr336-19322968211007212","unstructured":"D-Pocket Image. Provided by DiaMonTech AG. Accessed January 5, 2021."},{"key":"bibr337-19322968211007212","unstructured":"GlucoBeam. Provided by Dorte Pamperin of RSP Systems. Accessed January 5, 2021."},{"key":"bibr338-19322968211007212","unstructured":"GlucoQuantum Image. Provided by William Chee of Genki Vantage Ltd. Accessed January 5, 2021."},{"key":"bibr339-19322968211007212","unstructured":"LifeLeaf Image. Provided by Sweta Moitra of LifePlus. Accessed January 5, 2021."},{"key":"bibr340-19322968211007212","unstructured":"Movano Inc. Accessed January 4, 2021. https:\/\/movano.com\/"},{"key":"bibr341-19322968211007212","unstructured":"About. Know LABS. Accessed January 5, 2021. https:\/\/www.knowlabs.co\/about"},{"key":"bibr342-19322968211007212","unstructured":"SynerG Image. Provided by Thomas Seidl of Pacific Diabetes Technologies. Accessed January 5, 2021."},{"key":"bibr343-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31535-5"},{"key":"bibr344-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0223-6"},{"key":"bibr345-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820958754"},{"key":"bibr346-19322968211007212","unstructured":"About Us \u2013 Infinovo CGM. Accessed February 9, 2021. https:\/\/www.infinovo.co.uk\/about-us\/"},{"key":"bibr347-19322968211007212","unstructured":"Conley D. Two paths for medical device approval: FDA vs. CE. HealthManagement. 2015;15(2). Accessed February 12, 2021. https:\/\/healthmanagement.org\/c\/healthmanagement\/issuearticle\/two-paths-for-medical-device-approval-fda-vs-ce"},{"key":"bibr348-19322968211007212","unstructured":"CE Mark or FDA Approval? Guided Solutions. November 5, 2018. Accessed February 12, 2021. https:\/\/www.guidedsolutions.co.uk\/blog\/ce-mark-or-fda-approval\/"},{"key":"bibr349-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2005.7.776"},{"key":"bibr350-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700517"},{"key":"bibr351-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814539589"},{"key":"bibr352-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0509"},{"key":"bibr353-19322968211007212","unstructured":"Advanced diabetes technology poised to play larger role in care, management. Accessed February 12, 2021. https:\/\/www.healio.com\/news\/endocrinology\/20201210\/advanced-diabetes-technology-poised-to-play-larger-role-in-care-management"},{"key":"bibr354-19322968211007212","unstructured":"Continuous Glucose Monitoring Systems (CGMS) Market 2020-2027 - ResearchAndMarkets.com. July 22, 2020. Accessed February 12, 2021. https:\/\/www.businesswire.com\/news\/home\/20200722005453\/en\/Continuous-Glucose-Monitoring-Systems-CGMS-Market-2020-2027\u2014ResearchAndMarkets.com"},{"key":"bibr355-19322968211007212","unstructured":"Close K. Dexcom 4Q20 \u2013 Record FY20 revenue of $1.93 billion (+31% YOY); \u201cgreater than 900,000\u201d Dexcom users globally; G7 ready for CE submission, but more data needed for FDA; newly launched Dexcom Ventures fund. Close Concerns Knowledgebase. February 11, 2021. Accessed February 12, 2021. https:\/\/www.closeconcerns.com\/knowledgebase\/r\/61daec87?utm_source=Closer+Look+Subscribers+2018&utm_campaign=b5ab6397b2-2021-02-11_Dexcom_and_AZ_4Q2002_11_2021&utm_medium=email&utm_term=0_c55d924bf1-b5ab6397b2-412261953"},{"key":"bibr356-19322968211007212","unstructured":"U.S. Food and Drug Administration. GlucoWatch G2 Biographer. August 26, 2002. Accessed December 17, 2020. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P990026S008b.pdf"},{"key":"bibr357-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1754-y"},{"key":"bibr358-19322968211007212","unstructured":"OrSense Receives European CE Mark Approval for Continuous Non-Invasive Glucose Monitoring System. June 20, 2007. Accessed December 17, 2020. https:\/\/www.businesswire.com\/news\/home\/20070620005465\/en\/OrSense-Receives-European-CE-Mark-Approval-for-Continuous-Non-Invasive-Glucose-Monitoring-System"},{"key":"bibr359-19322968211007212","unstructured":"C8 MediSensors. C8 MediSensors gains CE mark approval for the C8 MediSensors optical glucose monitor(TM) system for people with diabetes. Accessed December 17, 2020. https:\/\/www.prnewswire.com\/news-releases\/c8-medisensors-gains-ce-mark-approval-for-the-c8-medisensors-optical-glucose-monitortm-system-for-people-with-diabetes-175821951.html"},{"key":"bibr360-19322968211007212","unstructured":"Dolan B. The promise of wireless, non-invasive CGM. MobiHealthNews. Published April 7, 2010. Accessed December 17, 2020. https:\/\/www.mobihealthnews.com\/7184\/the-promise-of-wireless-non-invasive-cgm"},{"key":"bibr361-19322968211007212","first-page":"A102","volume":"53","author":"Forst T","year":"2004","journal-title":"Diabetes"},{"key":"bibr362-19322968211007212","doi-asserted-by":"publisher","DOI":"10.19080\/CTBEB.2017.06.555696"},{"key":"bibr363-19322968211007212","unstructured":"Abbott launches first glucose sport biosensor for athletes. Abbott. Accessed February 26, 2021. https:\/\/www.abbott.com\/corpnewsroom\/strategy-and-strength\/abbott-launches-first-glucose-sport-biosensor-for-athletes.html"},{"key":"bibr364-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816661735"},{"key":"bibr365-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14467"},{"key":"bibr366-19322968211007212","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002"},{"key":"bibr367-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1088\/0967-3334\/28\/3\/R01"},{"key":"bibr368-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1010-5"},{"key":"bibr369-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00433-6"},{"key":"bibr370-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815616133"},{"key":"bibr371-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1002\/9781444317992.ch1"},{"key":"bibr372-19322968211007212","first-page":"2315","volume":"13","author":"Thomas A","year":"2015","journal-title":"Internet Electron J Nanociencia Moletr\u00f3nica"},{"key":"bibr373-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2005.08.013"},{"key":"bibr374-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1021\/ac061414z"},{"key":"bibr375-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.12.025"},{"key":"bibr376-19322968211007212","doi-asserted-by":"publisher","DOI":"10.1007\/s11569-009-0076-9"},{"key":"bibr377-19322968211007212","unstructured":"Dahad N. Rockley Photonics to Deliver Glucose Monitoring for Apple Smartwatches. EETimes. Published May 4, 2021. Accessed May 11, 2021. https:\/\/www.eetimes.com\/rockley-photonics-to-deliver-glucose-monitoring-for-apple-smartwatches\/"},{"key":"bibr378-19322968211007212","unstructured":"Avery D. Apple may be adding blood-sugar monitor to upcoming Apple Watch. Daily Mail Science and Tech. Published May 3, 2021. Accessed May 11, 2021. https:\/\/www.dailymail.co.uk\/sciencetech\/article-9539021\/Apple-add-sensors-monitor-blood-sugar-alcohol-levels-upcoming-Apple-Watch.html"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968211007212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968211007212","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968211007212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:15:03Z","timestamp":1777400103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968211007212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":378,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/19322968211007212"],"URL":"https:\/\/doi.org\/10.1177\/19322968211007212","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]}}}